The Walt Disney Company (BIT:1DIS)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Sep 28, 2024	Sep 30, 2023	Oct 1, 2022	Oct 2, 2021	Oct 3, 2020
Cash & Equivalents	5,367	6,002	14,182	11,615	15,959	17,914
Cash & Short-Term Investments	5,367	6,002	14,182	11,615	15,959	17,914
Cash Growth	-9.86%	-57.68%	22.10%	-27.22%	-10.91%	230.64%
Accounts Receivable	13,402	10,258	10,064	10,653	11,007	10,873
Other Receivables	-	2,471	2,266	1,999	2,360	1,835
Receivables	13,402	12,729	12,330	12,652	13,367	12,708
Inventory	3,836	4,119	4,965	3,632	3,514	3,754
Restricted Cash	8	-	-	3	3	3
Other Current Assets	1,207	2,391	1,286	1,196	814	872
Total Current Assets	23,820	25,241	32,763	29,098	33,657	35,251
Property, Plant & Equipment	40,185	40,663	39,443	37,865	36,855	36,126
Long-Term Investments	8,671	4,459	3,080	3,218	3,935	3,903
Goodwill	73,314	73,326	77,067	77,897	78,071	77,689
Other Intangible Assets	9,639	10,739	13,061	14,837	17,115	19,173
Long-Term Accounts Receivable	1,000	1,000	1,300	600	800	-
Other Long-Term Assets	39,983	40,791	38,865	40,116	33,176	29,407
Total Assets	196,612	196,219	205,579	203,631	203,609	201,549
Accounts Payable	20,500	14,022	14,348	15,490	15,679	12,399
Accrued Expenses	-	3,672	3,061	3,447	3,482	2,925
Short-Term Debt	1,513	3,040	1,476	1,662	1,992	2,023
Current Portion of Long-Term Debt	4,219	3,805	2,854	1,408	3,874	3,688
Current Portion of Leases	-	774	777	651	678	784
Current Income Taxes Payable	-	2,473	2,276	378	-	-
Current Unearned Revenue	6,145	5,587	5,568	5,531	4,067	3,688
Other Current Liabilities	595	1,226	779	506	1,305	1,121
Total Current Liabilities	32,972	34,599	31,139	29,073	31,077	26,628
Long-Term Debt	36,531	38,970	42,101	45,299	48,540	52,917
Long-Term Leases	-	2,928	3,464	3,239	3,229	2,911
Long-Term Unearned Revenue	818	858	977	927	581	513
Long-Term Deferred Tax Liabilities	3,097	6,277	7,258	8,363	7,246	7,288
Other Long-Term Liabilities	9,438	7,065	7,628	8,352	6,580	7,329
Total Liabilities	82,856	90,697	92,567	95,253	101,385	104,037
Common Stock	59,515	58,592	57,383	56,398	55,471	54,497
Retained Earnings	59,109	49,722	46,093	43,636	40,429	38,315
Treasury Stock	-6,430	-3,919	-907	-907	-907	-907
Comprehensive Income & Other	-3,049	-3,699	-3,292	-4,119	-6,440	-8,322
Total Common Equity	109,145	100,696	99,277	95,008	88,553	83,583
Minority Interest	4,611	4,826	13,735	13,370	13,671	13,929
Shareholders' Equity	113,756	105,522	113,012	108,378	102,224	97,512
Total Liabilities & Equity	196,612	196,219	205,579	203,631	203,609	201,549
Total Debt	42,263	49,517	50,672	52,259	58,313	62,323
Net Cash (Debt)	-36,896	-43,515	-36,490	-40,644	-42,354	-44,409
Net Cash Per Share	-20.34	-23.77	-19.94	-22.25	-23.17	-24.56
Filing Date Shares Outstanding	1,798	1,811	1,830	1,824	1,818	1,810
Total Common Shares Outstanding	1,797	1,812	1,830	1,824	1,818	1,810
Working Capital	-9,152	-9,358	1,624	25	2,580	8,623
Book Value Per Share	60.74	55.57	54.25	52.09	48.71	46.18
Tangible Book Value	26,192	16,631	9,149	2,274	-6,633	-13,279
Tangible Book Value Per Share	14.58	9.18	5.00	1.25	-3.65	-7.34
Land	1,191	1,145	1,176	8,897	1,131	1,035
Machinery	-	28,279	26,358	24,409	24,008	22,976
Construction In Progress	6,294	4,728	6,285	4,814	4,521	4,449
Leasehold Improvements	-	1,082	1,058	1,037	1,058	1,028

Source: S&P Global Market Intelligence. Standard template. Financial Sources.